Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 58, Issue 5, 2008, Pages 1445-1450

  Poulopoulou, C ^a   Papadopoulou Daifoti, Z ^a   Hatzimanolis, A ^a   Fragiadaki, K ^a   Polissidis, A ^a   Anderzanova, E ^a   Davaki, P ^a   Katsiari, C G ^a   Sfikakis, P P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; POTASSIUM CHANNEL KV1.3;

ADULT; ARTICLE; BLOOD LEVEL; CHANNEL GATING; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; PATCH CLAMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADOLESCENT; ADULT; FEMALE; GLUTAMIC ACID; HUMANS; KV1.3 POTASSIUM CHANNEL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

EID: 43949133868     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23446     Document Type: Article

References (15)

1. Krishnan S, Chowdhury B, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006;18:230-43.
2. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 1995;155:2269-81.
3. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11-21.
4. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 2004;25:280-9.
5. Panyi G, Vamosi G, Bacso Z, Bagdany M, Bodnar A, Varga Z, et al. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc Natl Acad Sci U S A 2004;101:1285-90.
6. Pacheco R, Gallart T, Lluis C, Franco R. Role of glutamate on T-cell mediated immunity. J Neuroimmunol 2007;185:9-19.
7. Lombardi G, Dianzani C, Miglio G, Canonico PL, Fantozzi R. Characterization of ionotropic glutamate receptors in human lymphocytes. Br J Pharmacol 2001;133:936-44.
8. Poulopoulou C, Markakis I, Davaki P, Nikolaou C, Poulopoulos A, Raptis E, et al. Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate. Mol Pharmacol 2005;67:856-67.
9. Chiocchetti A, Miglio G, Mesturini R, Varsaldi F, Mocellin M, Orilieri E, et al. Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol 2006;148:760-8.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang DH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
11. Bongiovanni R, Yamamoto BK, Jaskiw GE. Improved method for the measurement of large neutral amino acids in biological matrices. J Chromatogr B Biomed Sci Appl 2001;754:369-76.
12. Pawlak J, Brito V, Kuppers E, Beyer C. Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res 2005;138:1-7.
13. Yokoyama M, Suzuki E, Sato T, Maruta S, Inada K, Watanabe S, et al. Effects of intraperitoneal administration of IFN-α for one, four, and fourteen days on amino acid levels in various rat brain regions. J Interferon Cytokine Res 2005;25:187-91.
14. Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 2006;103:17414-9.
15. Nicolaou SA, Szigligeti P, Neumeier L, Lee SM, Duncan HJ, Kant SK, et al. Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus. J Immunol 2007;179:346-56.